PFG Investments’s Oncolytics Biotech ONCY Stock Holding History

PFG Investments’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$122K	Buy	128,300 +75,400	+143%	+$69.9K	﹤0.01%	1214
2026 Q1	$44.9K	Buy	52,900 +30,000	+131%	+$29.8K	﹤0.01%	1161
2025 Q4	$20K	Buy	22,900 +2,400	+12%	+$2.59K	﹤0.01%	1140
2025 Q3	$28.7K	Buy	20,500 +6,575	+47%	+$7.36K	﹤0.01%	1097
2025 Q2	$10.8K	Buy	13,925 +1,000	+8%	+$530	﹤0.01%	1039
2025 Q1	$7.11K	Buy	12,925 +2,000	+18%	+$1.46K	﹤0.01%	1013
2024 Q4	$9.98K	Buy	10,925 +425	+4%	+$442	﹤0.01%	1022
2024 Q3	$9.15K	Hold	10,500	–	–	﹤0.01%	1011
2024 Q2	$10.4K	Hold	10,500	–	–	﹤0.01%	933
2024 Q1	$11.1K	Buy	+10,500	New	+$11.7K	﹤0.01%	1033

Other funds holding ONCY

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

BPWM

Badgley Phelps Wealth Managers Seattle, Washington $5.71B AUM 30.33% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

PFG Investments's ONCY Position: Q2 2026 in Review

PFG Investments increased its Oncolytics Biotech (ONCY) stake by 143% in Q2 2026, buying an estimated $69.9K and bringing the position to 128,300 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #1214.

PFG Investments first reported a position in ONCY in Q1 2024 and has held it in 10 quarters since. 24 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

PFG Investments held 128,300 shares of Oncolytics Biotech worth $122K as of Q2 2026.
PFG Investments bought 75,400 Oncolytics Biotech shares in Q2 2026, an estimated $69.9K.
Oncolytics Biotech made up ﹤0.01% of PFG Investments's portfolio in Q2 2026, its #1214 holding.
PFG Investments first reported a position in Oncolytics Biotech in Q1 2024 and has held it in 10 quarters since.
24 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.